Meiwu Technology Company Limited Announces 1 for 20 Reverse Share Split
SHENZHEN, China, March 28, 2025 (GLOBE NEWSWIRE) — Meiwu Technology Company Limited (NASDAQ: WNW) announced today that its Board of Directors approved a 1 for 20 reverse share split of its ordinary shares on March 5, 2025. Shareholders will receive one new ordinary share for every twenty shares they hold. The Company’s ordinary shares are expected to begin trading on a split-adjusted basis on April 1, 2025.
The reverse share split is anticipated to increase the Company’s ordinary share trading price to approximately twenty times the pre-split price. However, the Company cannot guarantee that the post-split share price will maintain this ratio or remain above the pre-split trading price.
As of March 21, 2025, there were approximately 63.3 million ordinary shares outstanding. The reverse split will reduce this number to approximately 3.2 million shares. The Company’s authorized shares will remain unchanged.
The reverse split will proportionally adjust the number of ordinary shares underlying outstanding stock options and restricted shares, as well as their exercise prices. Fractional shares resulting from the reverse split will be rounded up to the nearest whole share.
Shareholders holding shares electronically in book-entry form do not need to take action to receive post-split shares. Those holding shares through a securities broker or nominee will be contacted with instructions. For more information, shareholders and securities brokers can contact TranShare at (303) 662-1112.
About Meiwu Technology Company Limited
Meiwu Technology Company Limited is a British Virgin Islands company incorporated on December 4, 2018. The Company has transitioned its business to the skincare industry and currently sells functional skincare products through its indirect wholly-owned subsidiary, Xiamen Chunshang Health Technology Co., Ltd., in China.
Safe Harbor Statement
Certain statements in this release are “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those discussed. Important factors include the ability to manage growth, obtain additional financing, and fluctuations in economic conditions. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law.
For more information, please contact: Zhichao Yang Email: meiwuBS@usmeiwu.com
